Literature DB >> 21653774

Comparison of serial Hepatitis C virus detection in samples submitted through serology for reflex confirmation versus samples directly submitted for quantitation.

Howard B Gale1, D Robert Dufour, Nazia N Qazi, Virginia L Kan.   

Abstract

Using real-time technology, we reliably identified chronic hepatitis C virus (HCV) infection and quantified virus from reflex samples originally submitted for serologic testing. There was no need to process specimens obtained directly for quantitation separately. Whether the initial source is a reflex sample or one obtained directly, a repeat HCV RNA test is needed before starting treatment.

Entities:  

Mesh:

Year:  2011        PMID: 21653774      PMCID: PMC3147769          DOI: 10.1128/JCM.00577-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Chemiluminescence assay improves specificity of hepatitis C antibody detection.

Authors:  D Robert Dufour; Mageli Talastas; Maria D A Fernandez; Barbara Harris
Journal:  Clin Chem       Date:  2003-06       Impact factor: 8.327

2.  Natural fluctuations of hepatitis C viral load in a homogeneous patient population: a prospective study.

Authors:  L Fanning; E Kenny-Walsh; J Levis; K R Choudhury; B Cannon; M Sheehan; M Whelton; F Shanahan
Journal:  Hepatology       Date:  2000-01       Impact factor: 17.425

3.  Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention.

Authors:  Miriam J Alter; Wendi L Kuhnert; Lyn Finelli
Journal:  MMWR Recomm Rep       Date:  2003-02-07

4.  Fluctuation of serum HCV-RNA levels in untreated blood donors with chronic hepatitis C virus infection.

Authors:  I K Kuramoto; T Moriya; V Schoening; P V Holland
Journal:  J Viral Hepat       Date:  2002-01       Impact factor: 3.728

5.  Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

Authors:  Gary L Davis; John B Wong; John G McHutchison; Michael P Manns; Joann Harvey; Janice Albrecht
Journal:  Hepatology       Date:  2003-09       Impact factor: 17.425

6.  Performance attributes of the LCx HCV RNA quantitative assay.

Authors:  Gregor Leckie; George Schneider; Klara Abravaya; Robert Hoenle; Julie Johanson; John Lampinen; Reuben Ofsaiof; Lisa Rundle; Shruti Shah; Andrea Frank; Dan Toolsie; Roy Vijesurier; Hong Wang; John Robinson
Journal:  J Virol Methods       Date:  2004-02       Impact factor: 2.014

7.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

Authors:  Michael W Fried; Mitchell L Shiffman; K Rajender Reddy; Coleman Smith; George Marinos; Fernando L Gonçales; Dieter Häussinger; Moises Diago; Giampiero Carosi; Daniel Dhumeaux; Antonio Craxi; Amy Lin; Joseph Hoffman; Jian Yu
Journal:  N Engl J Med       Date:  2002-09-26       Impact factor: 91.245

Review 8.  Natural history of hepatitis C infection: a concise review.

Authors:  J K Lim
Journal:  Yale J Biol Med       Date:  2001 Jul-Aug

9.  Significance of anti-HCV signal-to-cutoff ratio in predicting hepatitis C viremia.

Authors:  Yeon Seok Seo; Eun Suk Jung; Jeong Han Kim; Young Kul Jung; Ji Hoon Kim; Hyonggin An; Hyung Joon Yim; Jong Eun Yeon; Kwan Soo Byun; Chang Duck Kim; Ho Sang Ryu; Soon Ho Um
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 3.165

10.  Stable hepatitis C virus RNA detection by RT-PCR during four days storage.

Authors:  Anne-Isabelle de Moreau de Gerbehaye; Monique Bodéus; Annie Robert; Yves Horsmans; Patrick Goubau
Journal:  BMC Infect Dis       Date:  2002-10-04       Impact factor: 3.090

View more
  5 in total

1.  Hepatitis C Management Simplification From Test to Cure: A Framework for Primary Care Providers.

Authors:  Shashi N Kapadia; Kristen M Marks
Journal:  Clin Ther       Date:  2018-07-05       Impact factor: 3.393

2.  Testing for HCV infection: an update of guidance for clinicians and laboratorians.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-05-10       Impact factor: 17.586

3.  Scaling up the in-hospital hepatitis C virus care cascade in Taiwan.

Authors:  Chung-Feng Huang; Pey-Fang Wu; Ming-Lun Yeh; Ching-I Huang; Po-Cheng Liang; Cheng-Ting Hsu; Po-Yao Hsu; Hung-Yin Liu; Ying-Chou Huang; Zu-Yau Lin; Shinn-Cherng Chen; Jee-Fu Huang; Chia-Yen Dai; Wan-Long Chuang; Ming-Lung Yu
Journal:  Clin Mol Hepatol       Date:  2020-12-03

4.  Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study).

Authors:  Jee-Fu Huang; Ming-Yen Hsieh; Yu-Ju Wei; Jen-Yu Hung; Hsuan-Ti Huang; Ching-I Huang; Ming-Lun Yeh; Chung-Feng Huang; Tyng-Yuan Jang; Po-Yao Hsu; Po-Cheng Liang; Chia-Yen Dai; Zu-Yau Lin; Ming-Lung Yu; Wan-Long Chuang
Journal:  Hepatol Int       Date:  2021-11-30       Impact factor: 9.029

5.  Point-of-care hepatitis C reflex testing and treatment referral in methadone clinic settings in Hong Kong-a pilot study.

Authors:  Ngai-Sze Wong; Denise Pui-Chung Chan; Chin-Pok Chan; Chin-Man Poon; Grace Lai-Hung Wong; Vincent Wai-Sun Wong; Shui-Shan Lee
Journal:  IJID Reg       Date:  2022-08-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.